Aspen Pharmacare 

€10.1
21
+€0+0% Friday 06:03

統計

當日最高
10.1
當日最低
10.1
52週最高
-
52週最低
-
成交量
0
平均成交量
-
市值
5.46B
市盈率
21.61
股息收益率
1.8%
股息
0.18

即將到來

股息

1.8%股息收益率
10年增長
N/A
5年增長率
N/A
3年增長率
6.39%
1年增長率
6.61%

收益

3Sep預期
Q4 2023
Q2 2024
0.31
0.37
0.44
0.5
預期每股收益
0.4990768145999999
實際每股收益
0.4990768145999999

人們還關注

此列表基於在 Stock Events 上關注 LDZA.F 的人的關注列表。這不是投資建議。

競爭者

這個列表是基於最近市場事件的分析。這不是投資建議。

關於

Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty and branded pharmaceutical products worldwide. It operates in Commercial Pharmaceuticals and Manufacturing segments. The company provides general, local, and regional anesthetic; low molecular weight heparin; regional and spinal anesthetic; and opioid analegesic under the Diprivan, Emla, Fraxiparine, Marcaine, Ultiva, and Xylocaine brand names. It also offers such as sleeping aid, thyroid hormone, immunosuppressant, iron supplement, analgesic anti-inflammatory, and hormone replacement therapy under the Circadin, Eltroxin, Foxair, Imuran, Maltofer, Mybulen, and Ovestin brand names. In addition, the company manufactures and sells active pharmaceutical ingredients and finished dose form products. Aspen Pharmacare Holdings Limited was founded in 1850 and is headquartered in Durban, South Africa.
Show more...
首席執行官
Mr. Stephen Bradley Saad BCom, CA(SA)
員工
8612
國家
ZA
ISIN
ZAE000066692
WKN
000A0ET80

上市公司